Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban versus enoxaparin/warfarin for planned electrical cardioversion in nonvalvular atrial fibrillation
2013-003148-21Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Atrial fibrillation (AFib) and stroke comparing Edoxaban arm with Enoxaparin/warfarin followed by warfarin arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Feb 2014; status: completed.
02
Drugs
edoxabanenoxaparinwarfarin
03
Conditions
Atrial fibrillation (AFib)stroke
Beyond the preview
Go deeper on 2013-003148-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003148-21.